Revise phase III CT protocol of Recombinant Rabies G Protein Vaccine to add safety: CDSCO Panel tells Cadila Dr. Divya Colin4 Dec 2022 1:44 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the vaccine...
COVID trials improved diversity recruiting, says Moderna Top Scientist Ruchika Sharma3 Dec 2022 4:00 PM ISTNew York: Moderna Inc's top scientist has said that the vaccine maker has learned how to better recruit from diverse populations for its clinical...
CDSCO nod to World's first intra-nasal COVID vaccine for restricted use Ruchika Sharma2 Dec 2022 12:00 PM ISTVaccine is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein.
Study provides reassuring data on the risk of kidney disease relapse after COVID-19 vaccination Dr. Kamal Kant Kohli1 Dec 2022 8:00 PM ISTSeveral reports have described a relapse of certain autoimmune kidney diseases in patients after they've received COVID-19 vaccines, but it's unclear...
Holding mycophenolate mofetil for 10 days or more may improve COVID-19 vaccine response Dr. Kamal Kant Kohli29 Nov 2022 8:00 PM ISTNew research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that withholding...
Karnal Govt hospitals reels under shortage of Pneumococcal Conjugate Vaccines Revu suresh29 Nov 2022 11:00 AM ISTKarnal: Due to an irregular supply of Pneumococcal Conjugate Vaccine (PCV) by the Centre, the Government hospitals in the Karnal district of Haryana...
PGI Chandigarh to conduct joint study on Covishield and Covaxin combination Revu suresh28 Nov 2022 9:45 AM ISTChandigarh: A first-of-its kind study on Covid vaccines to understand the immunologic response, tolerability, and side effects of Covishield and...
Multivalent mRNA vaccine candidate another step closer to universal flu vaccine Dr. Kamal Kant Kohli27 Nov 2022 8:00 PM ISTClaudia Arevalo and colleagues have developed a mRNA lipid nanoparticle vaccine that contains antigens from all 20 known subtypes of influenza A and B...
Shionogi seeks Japenese nod for COVID Recombinant Protein-based Vaccine S-268019 Ruchika Sharma27 Nov 2022 1:30 PM ISTOsaka: Shionogi & Co., Ltd. has announced that it has filed for manufacturing and sales approval of S-268019, a recombinant protein-based...
DCGI gives nod to Bharat Biotech Intranasal 'Five Arms' COVID booster dose for restricted use Ruchika Sharma26 Nov 2022 11:30 AM ISTThe nasal vaccine can be taken after six months of the second dose. As this is non-invasive and needle-free, it becomes easy to administer.
Remdesivir with corticosteroids reduces mortality in COVID-19 patients in ICU: Study Dr. Kamal Kant Kohli23 Nov 2022 8:30 PM ISTJapan: Remdesivir use within 9 days from symptom onset among COVID-19 patients who received corticosteroids in ICU reduced in-hospital mortality risk,...
Takeda Dengue Vaccine TAK-003 gets USFDA priority review Ruchika Sharma23 Nov 2022 5:00 PM ISTTakeda's tetravalent dengue vaccine candidate (TAK-003) is based on a live-attenuated dengue serotype 2 virus, which provides the genetic "backbone"...
